Intrommune Therapeutics is a New York City-based biotechnology company with a mission to develop safe and effective food allergy treatments. They are dedicated to providing allergy sufferers and their loved ones the opportunity to live their lives without fear. Intrommune specializes in simplifying allergy immunotherapy through their core technology, which allows immunotherapeutic agents to be delivered in a specially formulated toothpaste.

This unique approach, known as oral mucosal immunotherapy (OMIT), delivers allergenic proteins to the oral cavity, potentially driving the immune system toward tolerance without ingesting the allergen. Intrommune's focus is on treating peanut and other food allergies, addressing a significant healthcare need in today's world where food allergies are on the rise. Their goal is to develop safe, effective, and easy-to-use health solutions for individuals suffering from food allergies, providing them and their loved ones with peace of mind